Clinical Study
CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study
Table 5
Combination
of polymorphisms mEH and GSTM1 and risk of oropharyngeal cancer.
| | Combination of genetic polymorphisms | Cases | Controls | OR crude | OR adjusted |
| | mEH
(Arg/Arg)/GSTM1 present | 31 | 48 | 1.00 | 1.00 | | mEH (Arg/Arg)/GSTM1
absent | 32 | 40 | 1.22 (0.63–2.36) | 1.45 (0.66–3.17) | | mEH mutated/GSTM1
present | 14 | 20 | 1.15 (0.50–2.65) | 1,19 (0.43–3.27) | | mEH mutated/GSTM1
absent | 15 | 22 | 1.18 (0.52–2.66) | 1.07 (0.39–2.92). |
|
|
